TY - JOUR
KW - Uk
KW - chronic rhinosinusitis with nasal polyps
KW - healthcare resource utilisation
KW - nasal polyps
KW - nasal surgery
KW - Prevalence
KW - retrospective
AU - V. Benson
AU - Q. Fu
AU - S. Yang
AU - A. Sousa
AU - R. Chan
AU - P. Howarth
AU - C. Hopkins
AD - Epidemiology, Value Evidence and Outcomes, GSK, GSK House, Brentford, Middlesex, UK.
Value Evidence and Outcomes, GSK, Collegeville, Pennsylvania, USA.
Respiratory Clinical Sciences R&D, GSK House, Brentford, Middlesex, UK.
Global Medical Affairs, GSK, Brentford, Middlesex, UK.
ENT Department, Guys and St Thomas's Hospital, London, UK.
King's College Hospital, London, UK.
AN - 37129235
BT - Clin Otolaryngol
DO - 10.1111/coa.14070
DP - NLM
ET - 2023/05/02
LA - eng
N1 - 1749-4486
Benson, Victoria S
Orcid: 0000-0002-3775-1401
Fu, Qinggong
Yang, Shibing
Sousa, Ana R
Chan, Robert H
Howarth, Peter
Hopkins, Claire
Orcid: 0000-0003-3993-1569
213951/gsk/
Journal Article
England
Clin Otolaryngol. 2023 May 2. doi: 10.1111/coa.14070.
PY - 2023
SN - 1749-4478
T2 - Clin Otolaryngol
TI - Real-world characterisation of patients with chronic rhinosinusitis with nasal polyps with and without surgery in England
ER -